Skip to main content
Fig. 4 | BMC Genomics

Fig. 4

From: Upregulation of CALD1 predicted a poor prognosis for platinum-treated ovarian cancer and revealed it as a potential therapeutic resistance target

Fig. 4

The CALD1 protein expression level of various kinds of cancers analyzed by CCLE. The expression of CALD1 in ovarian cancer was higher than that of many cancer types like lung cancer, breast cancer, head and neck cancer, esophageal cancer, pancreatic cancer, gastric cancer, colon/colorectal cancer, myeloma, leukemia, lymphoma. The results were statistically significant. The red box with the red arrow represented ovarian tumor.(* indicates P < 0.05, ** indicates P < 0.01, *** indicates P < 0.001)

Back to article page

BMC Genomics

ISSN: 1471-2164

Contact us